---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-057435"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2022-09-20T23:59:59+00:00"
generated_at: "2026-06-23T08:36:57.187591+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics appoints Alfred J. Novak to board; two director changes

## Summary
- Dr. Yassine Bendiabdallah resigned from board on Sept 14, 2022, with no disagreement.
- Dr. Lawrence Steinman resigned from audit committee, remaining on board and as chair of nominating committee.
- Alfred J. Novak appointed to board and audit committee; experienced healthcare executive and former CEO/CFO.
- Mr. Novak previously served on boards of Dova Pharmaceuticals (DOVA), LivaNova (LIVN), and others.

## SEC filing metadata
- accession: 0001213900-22-057435
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2022-09-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390022057435/0001213900-22-057435-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390022057435/ea165864-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-057435
- JSON: https://secwatch.observer/filing/0001213900-22-057435.json
- Plain text: https://secwatch.observer/filing/0001213900-22-057435.txt

## Key facts
- Executive change
  Yassine Bendiabdallah resigned as Director at Pasithea Therapeutics Corp..
  - Action: resigned
  - Role: Director
  source text: On September 14, 2022, Dr. Yassine Bendiabdallah resigned from the board of directors (the “Board”) of Pasithea Therapeutics Corp. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841330/000121390022057435/0001213900-22-057435-index.htm
- Executive change
  Alfred J. Novak was appointed as Director at Pasithea Therapeutics Corp..
  - Action: appointed
  - Role: Director
  source text: Concurrently, the Board appointed Alfred J. Novak to the Board and to its audit committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841330/000121390022057435/0001213900-22-057435-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.